BACE1 and early-onset autosomal dominant Alzheimer disease: Similarly, miR-135b was demonstrated to exert a neuroprotective role via direct targeting of β-site APP-cleaving enzyme 1 (BACE1) in Alzheimer's disease (AD) [31].